Corstasis Therapeutics
Henderson
About Corstasis Therapeutics
Corstasis Therapeutics offers therapeutic options for fluid overload recovery associated with congestive heart failure and kidney diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Series A (Jan 2026)
- Website: corstasis.com
- Phone: +1 702-541-9222
Industries & Categories
Health Care, Home Health Care, Outpatient Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/corstasis-therapeutics-224575 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.